Oncternal Therapeutics Inc (ONCT)
NASDAQ:ONCT
US Market
Holding ONCT?
Track your performance easily

Oncternal Therapeutics (ONCT) Financial Statements

467 Followers

Oncternal Therapeutics Financial Overview

Oncternal Therapeutics's market cap is currently ―. The company's EPS TTM is $-12.179; its P/E ratio is -0.13; Oncternal Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-3.19. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 801.00K$ 569.00K$ 582.00K$ 179.00K$ 106.00K
Gross Profit$ 801.00K$ 569.00K$ 297.00K$ 179.00K$ 106.00K
EBIT$ -8.56M$ -8.78M-$ -10.39M$ -8.97M
EBITDA$ -8.56M$ -8.78M-$ -10.39M$ -9.43M
Net Income Common Stockholders$ -8.56M$ -8.39M$ -9.16M$ -9.86M$ -8.97M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.43M$ 27.03M$ 34.26M$ 40.30M$ 45.50M
Total Assets$ 23.86M$ 29.14M$ 36.73M$ 43.20M$ 50.77M
Total Debt$ 235.00K$ 278.00K$ 318.00K$ 342.00K$ 366.00K
Net Debt$ -21.19M$ -26.75M$ -33.94M$ -39.96M$ -45.14M
Total Liabilities$ 8.11M$ 6.21M$ 6.68M$ 6.20M$ 5.59M
Stockholders Equity$ 15.78M$ 22.89M$ 30.05M$ 37.00M$ 45.14M
Cash Flow-
Free Cash Flow$ -5.82M$ -7.44M$ -6.42M$ -5.51M$ -9.26M
Operating Cash Flow$ -5.82M$ -7.44M$ -6.42M$ -5.51M$ -9.26M
Investing Cash Flow$ 5.81M$ 7.22M$ -1.81M$ 4.66M$ 13.85M
Financing Cash Flow-$ -87.00K$ -1.00K$ -49.00K$ -1.00K
Currency in USD

Oncternal Therapeutics Earnings and Revenue History

Oncternal Therapeutics Debt to Assets

Oncternal Therapeutics Cash Flow

Oncternal Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis